Clinical Trials Logo

Clinical Trial Summary

Transposition of great vessels are usually corrected by an arterial switch operation. This operation is often done during the first week of life as surgical delays lead to deconditioned left ventricle. On the other hand early surgery carries also risks as neonatal physiology may have problems adapting to an intervention under cardiopulmonary bypass, possible pulmonary hypertension. Arterial switch operation between 2008 and 2020 done at our center will be reviewed. Primary outcome will be mortality or severe postoperative morbidity. Patients will be divided in 2 groups according to the presence or absence of the primary outcome. After propensity score matching, they will be analysed according to the timing of operation.


Clinical Trial Description

Scientific background and motivation The transposition of great vessels (TGV) is a congenital heart defect in which the aorta follows the right ventricle and the pulmonary artery follows the left ventricle. At birth, the pulmonary and systemic circulations work in parallel and the communication between them depends on shunts in the cardiac stage (permeability of the Botal hole) or in the supra-cardiac (ducis arteriosus). It's the most common congenital heart disease and his incidence is estimated between 0.7 and 0.8 per 1000 births. It's a pathology that may be associated with other heart defects, such as interventricular communication (IVC) or pulmonary stenosis, but rarely with a chromosomal abnormality or malformative syndrome. TGV's manifestation is an isolated cyanosis, refractory to oxygen. And mortality reaches 90% in the first year of life in absence of treatment. TGV's management has evolved over the last 50 years. First, thanks to the antenatal ultrasound diagnosis, allowing early strategies in postnatal to maintain a shunt between the two circulations (Prostaglandin and Balloon atrial septostomy). Then, by the evolution of corrective surgeries; indeed atrial repair techniques (Senning and Mustard) have given way to the arterial Switch with coronary reimplantation by microsurgery. When it's possible, the operation takes place during the first week of life. Indeed, it's well established that surgical delay leads to a risk of left ventricle's deconditioned4 and sometimes impaired brain growth. But the risks of a premature surgery are less clear: Operability of the newborn, ability to tolerate an intervention under extracorporeal circulation (ECC), difficulties related to physiological pulmonary arterial hypertension at birth must be considered in the operative indication. The ideal timing for surgery is still poorly defined. In 2014, Anderson et al showed better results for arterial Switches performed on the third day of life6. On the other hand, Kumar et al, also studied the relationship between operative timing and morbi/mortality of several congenital heart surgeries including the arterial Switch but they found no relationship between them. Study design The investigators would like to establish if there is a relationship between the age of the newborn at the time of surgery and postoperative morbi/mortality. Therefore, the investigators want to review all the medical records of children operated on a TGV by the arterial Switch technique at HUDERF between 2008 and 2020. The morbidity/mortality criteria observed will be the same as those usually used in studies conducted on paediatric cardiac surgery at HUDERF: 1. The data of interest will be extracted from a database built up over years summing up the medical records of cardiac operated patients since 2002. 2. Statistics: 2.1. Children will be divided into two groups according to the primary outcome (present or absent). They will be matched using a propensity analysis and then compared in terms of operating time. 2.2. The influence of operative time on the occurrence of the primary outcome will also be analysed by a linear regression technique in which the parameter "operating time" will be considered as a continuous variable. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05160116
Study type Observational
Source Brugmann University Hospital
Contact
Status Completed
Phase
Start date December 15, 2021
Completion date June 10, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05524324 - Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT N/A
Recruiting NCT04616222 - A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels
Completed NCT03833843 - Sudden Cardiac Death in Systemic Right Ventricle
Active, not recruiting NCT02588989 - Fibrosis, Valvular and Ventricular Function in Patients With TGA
Recruiting NCT04106479 - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Active, not recruiting NCT04335448 - Comprehensive Long-term Follow up of Adults With Arterial Switch Operation
Completed NCT01916499 - MRI Study After Arterial Switch Operation in Patients With Transposition of the Great Arteries N/A
Recruiting NCT05452720 - MASA Valve Early Feasibility Study N/A
Completed NCT03078413 - Late Function After Surgery for Transposition of the Great Arteries
Completed NCT00199771 - Hypertonic Saline Dextran in Pediatric Cardiac Surgery Phase 2
Completed NCT00703352 - Eplerenone in Systemic Right Ventricle Phase 4
Completed NCT00006183 - Comparison of Hematocrit Levels in Infant Heart Surgery Phase 3
Completed NCT00005190 - Reproduction and Survival After Cardiac Defect Repair N/A
Completed NCT03661385 - Nitric Oxide During Bypass for Arterial Switch Operation Phase 3
Completed NCT00837603 - Physical Training in Transposition of the Great Arteries N/A
Completed NCT00374088 - N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study) Phase 2
Completed NCT00000470 - Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest Phase 3
Completed NCT05089773 - Outcomes of Transposition of the Great Arteries After Arterial Switch Operation
Recruiting NCT05809310 - Effects Branch PA Stenting d-TGA, ToF and TA N/A
Not yet recruiting NCT04288596 - Canadian Adult Congenital Heart Disease Intervention Registry